Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jason Peterson Insider Profile
4 Followers
Jason Peterson, Senior Officer at Zelira Therapeutics, holds 74.59M shares in Zelira Therapeutics (Ticker: ZLDAF).
Jason Peterson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jason Peterson's holdings
Insider Roles
Senior Officer
Roles that Jason Peterson holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Dec 20, 2017 - Dec 20, 2018
Return:+66.10%
The most profitable trade made by Jason Peterson
Jason Peterson's Trading History
List of latest transactions for each holding click on a transaction to see Jason Peterson's performance on stock
You May Also Like
Jason Peterson insider profile FAQ
What is the percentage of profitable transactions made by Jason Peterson?
The percentage of profitable transactions made by Jason Peterson is ―.
What is the average return per transaction made by Jason Peterson?
The average return per transaction made by Jason Peterson is ―.
What stocks does Jason Peterson hold?
Jason Peterson holds: ZLDAF stocks.
What was Jason Peterson’s latest transaction?
Jason Peterson latest transaction was an Uninformative Buy of ―.
What was Jason Peterson's most profitable transaction?
Jason Peterson’s most profitable transaction was an Informative Sell of ZLDAF stock on December 20, 2017. The return on the trade was 66.10%.
What is Jason Peterson's role in Zelira Therapeutics?
Jason Peterson's role in Zelira Therapeutics is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.